MichalMrugMD
Nephrology • Birmingham, ALProfessor, Medicine, University of Alabama School of Medicine
Dr. Mrug is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
700 19th St S
Birmingham, AL 35233Phone+1 205-933-8101Fax+1 205-933-4497- Is this information wrong?
Education & Training
University of Alabama Medical CenterFellowship, Nephrology, 2002 - 2004
USA HealthResidency, Internal Medicine, 1999 - 2002
Karlovy University FOMClass of 1995
Certifications & Licensure
AL State Medical License 2002 - 2024- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- US Veterans Administration Autosomal Dominant Polycystic Kidney Disease Cohort: Demographic, Comorbidity and Key Laboratory Data Characteristics.Gallini, J., Jasien, C., Cui, X., Mrug, M.> ;Kidney360. 2024 Mar 1
- Distinct developmental reprogramming footprint of macrophages during acute kidney injury across species.Michal Mrug, Elias Mrug, Frida Rosenblum, Jiandong Chen, Xiangqin Cui, Anupam Agarwal, Abolfazl Zarjou> ;American Journal of Physiology. Renal Physiology. 2024 Apr 1
- nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease.Krishnan, C., Schmidt, E., Onuoha, E., Cardenas, C., Kim, H., Mrug, M.> ;Current Medical Imaging. 2024 Jan 1
- Join now to see all
Journal Articles
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanRonald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
Authored Content
- Baseline Total Kidney Volume and the Rate of Kidney Growth Are Associated with Chronic Kidney Disease Progression in Autosomal Dominant Polycystic Kidney DiseaseDecember 2017
Press Mentions
Otsuka’s JYNARQUE™ (Tolvaptan) Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD)April 24th, 2018
Hospital Affiliations
Birmingham VA Medical CenterBirmingham, Alabama
University of Alabama HospitalBirmingham, Alabama
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
